Form 4: TransMedics Group CFO Hernandez Reports Stock and Option Transactions

Chief Financial Officer Gerardo Hernandez of TransMedics Group, Inc. reports acquisition of restricted stock units and stock options.

Summary

• On February 24, 2025, Gerardo Hernandez, CFO of TransMedics Group, Inc., acquired 3,521 restricted stock units (RSUs), each representing a contingent right to receive one share of the company's common stock.
• Hernandez also acquired 5,299 stock options with an exercise price of $77.12 on the same date.
• These options vest monthly at a rate of 2.0833% starting February 24, 2025, and will be fully vested by February 24, 2029, contingent upon continued service.
• Following these transactions, Hernandez directly owns 15,984 shares of common stock and 5,299 stock options.
• The expiration date for the options is February 24, 2035.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard regulatory filing detailing stock and option transactions. The acquisition of shares and options by an executive can be seen as a positive signal, but it's a routine event.

Positives

• The acquisition of RSUs and stock options by the CFO could be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The document does not contain specific forward-looking statements, but the vesting schedule of the options suggests a multi-year commitment from the CFO.

Industry Context

This filing is a routine disclosure related to executive compensation and is common for publicly traded companies. It provides transparency into the holdings and transactions of key personnel.

Comparison to Industry Standards

• Stock option grants and RSU awards are standard components of executive compensation packages in the medical technology industry.
• Vesting schedules, such as the one described (monthly vesting over four years), are typical to incentivize long-term performance and retention.
• Comparing the size of the grant to those of CFOs at similarly sized medical device companies (e.g., Intuitive Surgical, Stryker, Medtronic) would provide further context on the competitiveness of the compensation package.

Stakeholder Impact

• The transactions could have a minor positive impact on shareholder sentiment, as they reflect the CFO's increased stake in the company.

Key Dates